Stocktoria
MILESTONE SCIENTIFIC INC. MLSS
MILESTONE SCIENTIFIC INC. (MLSS) earns a Piotroski F-score of 2/9 (weak financial health). It does not currently pay a dividend. FY2025 revenue was $9.0M at a -63.8% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Analyst price target
Wall Street analyst consensus — a sentiment gauge, not our scoring.
How it ranks in Manufacturing · percentile among 1957 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 2/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| MLSS | MILESTONE SCIENTIFIC INC. | 2/9 | — | — | — |
| FEED | ENvue Medical, Inc. | 2/9 | -6.2 | — | — |
| CLGN | CollPlant Biotechnologies Ltd | 3/9 | — | — | — |
| NTRB | NutriBand Inc. | 3/9 | -15.84 | — | — |
| AVR | Anteris Technologies Global Corp. | 2/9 | — | — | — |
| SPAI | Safe Pro Group Inc. | 4/9 | 9.05 | — | — |
| COCH | Envoy Medical, Inc. | 2/9 | — | — | — |
About MILESTONE SCIENTIFIC INC.
Milestone Scientific Inc., a biomedical technology company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical and dental use in the United States, China, and internationally. It operates through Dental and Medical segments. The company provides the Wand, a single use disposable handpiece device for dental procedures that require local anesthetic under the CompuDent and STA Single Tooth Anesthesia System names. It also offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances; and disposable injection handpiece for the tactile control during the injection. In addition, the company provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications. Further, it offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey.
FAQ
Is MLSS financially healthy?
MILESTONE SCIENTIFIC INC.'s Piotroski F-score is 2/9 (8–9 is excellent, 0–3 weak).
Does MLSS pay a dividend?
No, MILESTONE SCIENTIFIC INC. does not currently pay a dividend.
How profitable is MLSS?
In FY2025, MILESTONE SCIENTIFIC INC. had a net margin of -63.8% and a return on equity of -203.4%.
What is the analyst price target for MLSS?
The average Wall-Street price target for MILESTONE SCIENTIFIC INC. is $1.00, about 89.0% above the recent price, from 2 analysts.
Is MLSS a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on MILESTONE SCIENTIFIC INC.: a Piotroski F-score of 2/9. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.